Literature DB >> 18593901

c-Jun NH2-terminal kinase 1 is a critical regulator for the development of gastric cancer in mice.

Wataru Shibata1, Shin Maeda, Yohko Hikiba, Ayako Yanai, Kei Sakamoto, Hayato Nakagawa, Keiji Ogura, Michael Karin, Masao Omata.   

Abstract

c-Jun NH(2)-terminal kinase (JNK) links several cellular processes, including proliferation and survival, and is believed to be involved in carcinogenesis. However, the role of JNK in gastric tumorigenesis is unknown. Immunohistochemical analysis reveals that JNK is frequently activated in human gastric cancer tissue. We investigated whether JNK1, a major JNK isozyme, is involved in chemically induced gastric cancer development. Mice lacking JNK1 exhibited a marked decrease in gastric carcinogenesis induced by N-methyl-N-nitrosourea, relative to their wild-type counterparts. Impaired tumor development correlated with decreased tumor initiation, which is associated with the production of reactive oxygen species. We also found that lower levels of tumorigenesis were correlated with the decreased expression of cyclin D and CDK as well as decreased cell proliferation. Taken together, JNK seems to be involved in both tumor initiation and promotion and may be an attractive target for the prevention of gastric carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18593901     DOI: 10.1158/0008-5472.CAN-07-6332

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  44 in total

1.  Inhibitor of kappaB kinase beta regulates gastric carcinogenesis via interleukin-1alpha expression.

Authors:  Kei Sakamoto; Yohko Hikiba; Hayato Nakagawa; Yoku Hayakawa; Ayako Yanai; Masao Akanuma; Keiji Ogura; Yoshihiro Hirata; Klaus H Kaestner; Masao Omata; Shin Maeda
Journal:  Gastroenterology       Date:  2010-03-25       Impact factor: 22.682

2.  Apoptosis signal-regulating kinase 1 and cyclin D1 compose a positive feedback loop contributing to tumor growth in gastric cancer.

Authors:  Yoku Hayakawa; Yoshihiro Hirata; Hayato Nakagawa; Kei Sakamoto; Yohko Hikiba; Hiroto Kinoshita; Wachiko Nakata; Ryota Takahashi; Keisuke Tateishi; Motohisa Tada; Masao Akanuma; Haruhiko Yoshida; Kohsuke Takeda; Hidenori Ichijo; Masao Omata; Shin Maeda; Kazuhiko Koike
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

Review 3.  Targeting innate immunity protein kinase signalling in inflammation.

Authors:  Matthias Gaestel; Alexey Kotlyarov; Michael Kracht
Journal:  Nat Rev Drug Discov       Date:  2009-06       Impact factor: 84.694

4.  c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancer.

Authors:  Pablo Vivas-Mejia; Juliana Maria Benito; Ariel Fernandez; Hee-Dong Han; Lingegowda Mangala; Cristian Rodriguez-Aguayo; Arturo Chavez-Reyes; Yvonne G Lin; Mark S Carey; Alpa M Nick; Rebecca L Stone; Hye Sun Kim; Francois-Xavier Claret; William Bornmann; Bryan T J Hennessy; Angela Sanguino; Zhengong Peng; Anil K Sood; Gabriel Lopez-Berestein
Journal:  Clin Cancer Res       Date:  2009-12-22       Impact factor: 12.531

5.  JNK pathway inhibition enhances chemotherapeutic sensitivity to Adriamycin in nasopharyngeal carcinoma cells.

Authors:  Yong Liu; Jing Feng; Ming Zhao; Jingbo Wu; Juan Fan; Qinglian Wen; Jinhui Xu; Jianwen Zhang; Shaozhi Fu; Biqiong Wang; Yun Lu; Kang Xiong; Li Xiang; Yanling Zhang; Linglin Yang
Journal:  Oncol Lett       Date:  2017-06-08       Impact factor: 2.967

6.  Impact of JNK1, JNK2, and ligase Itch on reactive oxygen species formation and survival of prostate cancer cells treated with diallyl trisulfide.

Authors:  Alicja Sielicka-Dudzin; Andzelika Borkowska; Anna Herman-Antosiewicz; Michal Wozniak; Agnieszka Jozwik; Donatella Fedeli; Jedrzej Antosiewicz
Journal:  Eur J Nutr       Date:  2011-08-24       Impact factor: 5.614

7.  Loss of SPARC in bladder cancer enhances carcinogenesis and progression.

Authors:  Neveen Said; Henry F Frierson; Marta Sanchez-Carbayo; Rolf A Brekken; Dan Theodorescu
Journal:  J Clin Invest       Date:  2013-01-16       Impact factor: 14.808

8.  NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis.

Authors:  Shin Maeda
Journal:  Gastroenterol Res Pract       Date:  2010-11-28       Impact factor: 2.260

Review 9.  Signal integration by JNK and p38 MAPK pathways in cancer development.

Authors:  Erwin F Wagner; Angel R Nebreda
Journal:  Nat Rev Cancer       Date:  2009-08       Impact factor: 60.716

10.  Scribble mutants promote aPKC and JNK-dependent epithelial neoplasia independently of Crumbs.

Authors:  Gregory R Leong; Karen R Goulding; Nancy Amin; Helena E Richardson; Anthony M Brumby
Journal:  BMC Biol       Date:  2009-09-24       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.